dextroamphetamine has been researched along with Intraventricular Septal Defects in 2 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nora, JJ | 2 |
| Sommerville, RJ | 1 |
| Fraser, FC | 1 |
2 other studies available for dextroamphetamine and Intraventricular Septal Defects
| Article | Year |
|---|---|
Etiologic factors in congenital heart diseases.
Topics: Animals; Child, Preschool; Chromosome Aberrations; Counseling; Dextroamphetamine; Diseases in Twins; | 1971 |
Homologies for congenital heart diseases: murine models, influenced by dextroamphetamine.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Female; Heart Septal Defects, Atrial; Heart Sept | 1968 |